HARPOON THERAPEUTICS

harpoon-therapeutics-logo

Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the bodyโ€™s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patientโ€™s own T cells to kill target cells that express specific proteins, or antigens, carried by the target cells. Using its proprietary Tri-specific T cell Activating Construct๏ƒ” (TriTAC), platform, Harpoon is developing a pipeline of novel T cell engagers, or TriTACs, initially focused on the treatment of solid tumors and hematologic malignancies. Harpoon's first drug candidate, HPN424, is currently in Phase 1 clinical trial as a treatment for prostate cancer.

#SimilarOrganizations #People #Financial #Website #More

HARPOON THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2015-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.harpoontx.com

Total Employee:
51+

Status:
Active

Contact:
650-443-7400

Email Addresses:
[email protected]

Total Funding:
130 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Content Delivery Network Google Universal Analytics Apache Microsoft Exchange Online


Similar Organizations

aletheia-therapeutics-logo

Aletheia Therapeutics

Aletheia Therapeutics is a clinical-stage oncology therapeutics company that develops a paradigm shift in the treatment of cancer.

amcure-logo

amcure

amcure is a clinical-stage company develops peptide-based compounds for the treatment of highly metastatic forms of squamous cancer.

atara-biotherapeutics-logo

Atara Biotherapeutics

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

atsena-therapeutics-logo

Atsena Therapeutics

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

gamamabs-pharma-logo

GamaMabs Pharma

GamaMabs Pharma is a clinical-stage immuno-oncology company that developes optimized therapeutic antibodies for the treatment of cancer.

inspyr-therapeutics-logo

Inspyr Therapeutics

Inspyr Therapeutics is a clinical stage company focused on novel targeted precision therapeutics for the treatment of cancer.

gritstone-bio-logo

Gritstone Bio

Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.

guided-therapeutics-logo

Guided Therapeutics

Guided Therapeutics is a medical technology company developing biophotonics solutions for the non-invasive detection of cancer.

juno-therapeutics-logo

Juno Therapeutics

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

kurome-therapeutics-logo

Kurome Therapeutics

Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.

marker-therapeutics-logo

Marker Therapeutics

Marker Therapeutics is a clinical-stage developer of a transformative, non-genetically engineered, multi-antigen T cell therapy platform.

milestone-pharmaceuticals-logo

Milestone Pharmaceuticals

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

passage-bio-logo

Passage Bio

Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.

sierra-oncology-logo

Sierra Oncology

Sierra Oncology is a clinical-stage drug development company that advances targeted therapeutics for the treatment of cancer patients.

not_available_image

Valanbio Therapeutics

Valanbio Therapeutics is an early-stage anti-infectives company that develops novel antibiotics for Gram-negative organisms.


Current Advisors List

ron-hunt_image

Ron Hunt Board Member @ Harpoon Therapeutics
Board_member
2017-05-01

mark-chin_image

Mark Chin Board Member @ Harpoon Therapeutics
Board_member
2017-05-01

luke-evnin_image

Luke Evnin Board Chairman @ Harpoon Therapeutics
Board_member
2015-01-01

scott-myers_image

Scott Myers Board Member @ Harpoon Therapeutics
Board_member
2018-08-01

gerald-mcmahon_image

Gerald McMahon Board Member @ Harpoon Therapeutics
Board_member
2016-01-01

jonathan-drachman_image

Jonathan Drachman Board Member @ Harpoon Therapeutics
Board_member
2018-12-01

patrick-baeuerle_image

Patrick Baeuerle Board Member @ Harpoon Therapeutics
Board_member
2015-01-01

Current Employees Featured

gerald-mcmahon_image

Gerald McMahon
Gerald McMahon President & CEO @ Harpoon Therapeutics
President & CEO
2016-12-01

georgia-picht_image

Georgia Picht
Georgia Picht CFO @ Harpoon Therapeutics
CFO

luke-evnin_image

Luke Evnin
Luke Evnin Co-Founder @ Harpoon Therapeutics
Co-Founder

susan-d-jones_image

Susan D. Jones
Susan D. Jones Senior Vice President, Product Development @ Harpoon Therapeutics
Senior Vice President, Product Development
2017-06-01

che-leung-law_image

Che-Leung Law
Che-Leung Law Vice President @ Harpoon Therapeutics
Vice President

georgia-erbez_image

Georgia Erbez
Georgia Erbez Chief Financial Officer @ Harpoon Therapeutics
Chief Financial Officer
2018-10-01

natalie-sacks_image

Natalie Sacks
Natalie Sacks Chief Medical Officer @ Harpoon Therapeutics
Chief Medical Officer
2018-10-01

julie-eastland_image

Julie Eastland
Julie Eastland Chief Executive Officer @ Harpoon Therapeutics
Chief Executive Officer
2021-11-01

holger-wesche_image

Holger Wesche
Holger Wesche SENIOR VICE PRESIDENT @ Harpoon Therapeutics
SENIOR VICE PRESIDENT

Founder


luke-evnin_image

Luke Evnin

patrick-baeuerle_image

Patrick Baeuerle

Stock Details


Company's stock symbol is NASDAQ:HARP

Investors List

mpm-capital_image

MPM Capital

MPM Capital investment in Series C - Harpoon Therapeutics

ubs-asset-management_image

UBS Asset Management

UBS Asset Management investment in Series C - Harpoon Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series C - Harpoon Therapeutics

oncology-impact-fund_image

oncology impact fund

oncology impact fund investment in Series C - Harpoon Therapeutics

ns-investment_image

NS Investment

NS Investment investment in Series C - Harpoon Therapeutics

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series C - Harpoon Therapeutics

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Series C - Harpoon Therapeutics

ridgeback-capital_image

Ridgeback Capital

Ridgeback Capital investment in Series C - Harpoon Therapeutics

arix-bioscience_image

Arix Bioscience

Arix Bioscience investment in Series C - Harpoon Therapeutics

taiho-ventures-2_image

Taiho Ventures

Taiho Ventures investment in Series C - Harpoon Therapeutics

Official Site Inspections

http://www.harpoontx.com Semrush global rank: 3.44 M Semrush visits lastest month: 4.46 K

  • Host name: ad8242ffdb37e18fd.awsglobalaccelerator.com
  • IP address: 99.83.236.178
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Harpoon Therapeutics" on Search Engine